BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Salvatore Patanè. Regulator of G-protein signaling 6 (RGS6) in cardiology and oncologyInternational Journal of Cardiology 2015; 187: 99 doi: 10.1016/j.ijcard.2015.03.278
2
M. Scarano, F. Pezzuoli, G. Torrisi, G.M. Calvagna, S. Patanè. Cardiovascular implantable electronic device infective endocarditisInternational Journal of Cardiology 2014; 173(3): e38 doi: 10.1016/j.ijcard.2014.03.075
3
Antonio Maria Labate, Provvidenza Villari, Roberto La Rocca, Andrea Gervasio, Salvatore Patanè. Acute pulmonary embolism (PE) as the most serious clinical presentation of venous thromboembolism (VTE)International Journal of Cardiology 2015; 195: 225 doi: 10.1016/j.ijcard.2015.05.119
4
Salvatore Patanè. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3): 1306 doi: 10.1016/j.ijcard.2014.07.158
5
Pietro Pugliatti, Concetta Zito, Rosaria Adamo, Salvatore Calcaterra, Salvatore Patanè. Mitral valve prolapse caused from ruptured mitral chordae tendineae due to an infective endocarditis in cancer patientInternational Journal of Cardiology 2015; 195: 73 doi: 10.1016/j.ijcard.2015.05.113
6
Salvatore Patanè. Prostate-specific antigen kallikrein, non-ST elevation myocardial infarction and a new-onset atrial fibrillation in hypertensive patientsInternational Journal of Cardiology 2013; 167(1): 283 doi: 10.1016/j.ijcard.2012.09.208
7
Placido Romeo, Giuseppe Mario Calvagna, Marco Giunta, Felice Vito Vitale, Salvatore Patanè. Removal of an intracardiac lost port-A catheter utilizing a simple low-cost methodInternational Journal of Cardiology 2014; 176(3): 1309 doi: 10.1016/j.ijcard.2014.07.156
8
Salvatore Patanè. Cardiotoxicity: Cisplatin and long-term cancer survivorsInternational Journal of Cardiology 2014; 175(1): 201 doi: 10.1016/j.ijcard.2014.04.238
9
Salvatore Patanè. Cardiotoxicity: Trastuzumab and cancer survivorsInternational Journal of Cardiology 2014; 177(2): 554 doi: 10.1016/j.ijcard.2014.08.117
10
Salvatore Patanè. ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3): 1301 doi: 10.1016/j.ijcard.2014.07.161
11
Pietro Pugliatti, Antonino Recupero, Concetta Zito, Salvatore Patanè. The chance finding of an atrial septal defect in a cancer patientInternational Journal of Cardiology 2014; 177(2): e68 doi: 10.1016/j.ijcard.2014.09.153
12
Salvatore Patanè. Insights into cardio-oncology: The patient's heavy cancer journey among doubts, controversies and pitfalls. The role of the cardiologistInternational Journal of Cardiology 2015; 178: 175 doi: 10.1016/j.ijcard.2014.10.167
13
Salvatore Patanè. Prostate-specific antigen kallikrein and non-ST elevation myocardial infarctionInternational Journal of Cardiology 2011; 149(3): 392 doi: 10.1016/j.ijcard.2011.03.015
14
Meera Srivastava, Ofer Eidelman, James Craig, Joshua Starr, Leonid Kvecher, Jianfang Liu, Matthew Hueman, Harvey B Pollard, Hai Hu, Craig D Shriver. Serum Biomarkers for Racial Disparities in Breast Cancer ProgressionMilitary Medicine 2019; 184(Supplement_1): 652 doi: 10.1093/milmed/usy417
15
Salvatore Patanè. Cardiotoxicity: Anthracyclines and long term cancer survivorsInternational Journal of Cardiology 2014; 176(3): 1326 doi: 10.1016/j.ijcard.2014.07.149
16
Pietro Pugliatti, Rocco Donato, Cesare de Gregorio, Salvatore Patanè. A massive pericardial effusion in a cancer patientInternational Journal of Cardiology 2015; 181: 138 doi: 10.1016/j.ijcard.2014.11.141
17
Salvatore Patanè. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3): 1082 doi: 10.1016/j.ijcard.2014.07.129
18
Salvatore Patanè. M3 muscarinic acetylcholine receptor in cardiology and oncologyInternational Journal of Cardiology 2014; 177(2): 646 doi: 10.1016/j.ijcard.2014.09.178
19
Salvatore Patanè. Regulator of G-protein signaling 2 (RGS2) in cardiology and oncologyInternational Journal of Cardiology 2015; 179: 63 doi: 10.1016/j.ijcard.2014.10.088
20
Salvatore Patanè, Filippo Marte. Prostate-specific antigen levels in hypertensive patients suffering from a non-ST elevation myocardial infarction or a new-onset atrial fibrillationInternational Journal of Cardiology 2012; 158(3): 380 doi: 10.1016/j.ijcard.2011.01.066